Use of fenoldopam for the treatment of hemolytic uremic syndrome
AssigneeFondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico
InventorGianluigi ARDISSINO
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of fenoldopam, its salts and/or derivatives for the treatment of hemolytic uremic syndrome (HUS), preferably in the form due to infection from Shiga-like toxin-producing Escherichia coli and in the atypical form.
Claims12
A method for the treatment of hemolytic uremic syndrome which comprises administering an amount of fenoldopam, its salts and/or derivatives to a patient affected with hemolytic uremic syndrome where said amount of fenoldopam, its salts and/or derivatives is effective to treat said uremic syndrome.
Injectable sterile aqueous solution comprising fenoldopam together with one or more pharmaceutically acceptable excipients for use in medical field in the treatment of the hemolytic uremic syndrome.
Dependencies are inferred from the claim text.